Hypogonadism causes bone loss and increased bone metastases in a model of mixed osteolytic/osteoblastic metastases: Prevention by zoledronic acid

被引：0
|
作者：
Padalecki, SS [1 ]
Carreon, M [1 ]
Grubbs, B [1 ]
Guise, TA [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1590
页数：2
相关论文
共 50 条
  • [31] Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion
    Rosen, LS
    Gordon, DH
    Dugan, W
    Major, P
    Eisenberg, PD
    Provencher, L
    Kaminski, M
    Simeone, J
    Seaman, J
    Chen, BL
    Coleman, RE
    CANCER, 2004, 100 (01) : 36 - 43
  • [32] Zoledronic acid and atrial fibrillation in cancer patients with bone metastases
    Aksoy, S.
    Dizdar, O.
    Turgut, D.
    Dede, D. Sener
    Arslan, C.
    Harputluoglu, H.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] TREATMENT OF BONE METASTASES FROM HEPATOCELLULAR CARCINOMA WITH ZOLEDRONIC ACID
    Addeo, Raffaele
    Montella, Liliana
    Palmieri, Giovannella
    Caraglia, Michele
    Cennamo, Gregorio
    Guarrasi, Rosario
    Iodice, Patrizia
    Mamone, Rosanna
    Faiola, Vincenzo
    D'Agostino, Alberto
    Capasso, Elena
    Maiorino, Luigi
    Pizza, Carmine
    Montesarchio, Vincenzo
    Del Prete, Salvatore
    ANNALS OF ONCOLOGY, 2009, 20
  • [34] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [35] Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
    Chen, TL
    Berenson, J
    Vescio, R
    Swift, R
    Gilchick, A
    Goodin, S
    LoRusso, P
    Ma, PM
    Ravera, C
    Deckert, F
    Schran, H
    Seaman, J
    Skerjanec, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1228 - 1236
  • [36] Zoledronic acid (ZOMETA): a significant improvement in the treatment of bone metastases
    Nagy, Z
    PATHOLOGY & ONCOLOGY RESEARCH, 2005, 11 (03) : 186 - 187
  • [37] Low doses of zoledronic acid reduce complications of bone metastases
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (06): : 759 - +
  • [38] Regarding "Recommendations for zoledronic acid treatment of patients with bone metastases"
    Parles, K
    ONCOLOGIST, 2005, 10 (05): : 304 - 305
  • [39] BONE METASTASES IN NSCLC: THE ANTIANGIOGENIC EFFECT OF ZOLEDRONIC ACID (ZA)
    Quirino, M.
    Orlandi, A.
    Quaranta, A.
    Strippoli, A.
    Cursio, O. E.
    Di Lascio, S.
    Amoruso, A.
    Basso, M.
    Cassano, A.
    Barone, C.
    LUNG CANCER, 2011, 71 : S32 - S32
  • [40] Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases
    Oka, Shuntaro
    Kanagawa, Masaru
    Doi, Yoshihiro
    Schuster, David M.
    Goodman, Mark M.
    Yoshimura, Hirokatsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
12345